Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gottlieb Advances, But FDA's Future Seems Increasingly Partisan

Apr 27 2017

• By Derrick Gingery

Capitol House

Related Content

Hamburg Is One Step Closer To Commissioner’s Office As Senate Panel Endorses Nomination

May 13 2009

Califf's Priorities Feature Short- And Long-Term Goals Despite Potentially Brief Tenure

Feb 29 2016

Gottlieb Confirmation: Scheduling, Paperwork Delay Committee Vote One Day

Apr 26 2017

Opioid Policy At US FDA: Gottlieb Seeks More Activist Role To Combat Abuse

Apr 07 2017

Gottlieb's Confirmation: He's Willing To Disagree With Trump, Sec. Price

Apr 06 2017

Gottlieb's Confirmation: Will Industry Ties Remain A Big Deal After The Hearing?

Apr 03 2017

Califf Nomination Swimming Upstream With Multiple Holds Now Possible

Jan 12 2016

Cephalon Must Report Payments To Physicians In Settlement Of Off-Label Charges

Oct 06 2008

Related Companies

Cephalon, Inc.

Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Additional Topics

United States FDA Leadership Regulation Legislation BioPharmaceutical

More from US FDA

More from Agency Leadership

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window